BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2229317)

  • 21. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Schelbert HR
    J Nucl Med; 1992 Jul; 33(7):1263-6. PubMed ID: 1613562
    [No Abstract]   [Full Text] [Related]  

  • 22. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians.
    Paolisso G; Ravussin E
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1382-5. PubMed ID: 7714114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of regional rate of glucose metabolism in lumbar muscles in patients with generalized tendomyopathy using dynamic 18F-FDG PET].
    Frey LD; Locher JT; Hrycaj P; Stratz T; Kovac C; Mennet P; Müller W
    Z Rheumatol; 1992; 51(5):238-42. PubMed ID: 1476008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
    Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
    J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
    Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans.
    Blümer RM; van der Crabben SN; Stegenga ME; Tanck MW; Ackermans MT; Endert E; van der Poll T; Sauerwein HP
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E613-7. PubMed ID: 18577692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose uptake saturation explains glucose kinetics profiles measured by different tests.
    Bizzotto R; Natali A; Gastaldelli A; Muscelli E; Krssak M; Brehm A; Roden M; Ferrannini E; Mari A
    Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E346-57. PubMed ID: 27245333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism.
    Avogaro A; Valerio A; Miola M; Crepaldi C; Pavan P; Tiengo A; del Prato S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2285-90. PubMed ID: 8964865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose metabolism in noninsulin-dependent diabetic patients with experimental hyperthyroidism.
    Bratusch-Marrain PR; Komjati M; Waldhäusl WK
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1063-8. PubMed ID: 3889028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism in the 5' flanking region of the human insulin gene. Relationships with noninsulin-dependent diabetes mellitus, glucose and insulin concentrations, and diabetes treatment in the Pima Indians.
    Knowler WC; Pettitt DJ; Vasquez B; Rotwein PS; Andreone TL; Permutt MA
    J Clin Invest; 1984 Dec; 74(6):2129-35. PubMed ID: 6392341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional differences in cerebral blood flow and glucose utilization in diabetic man: the effect of insulin.
    Cranston I; Marsden P; Matyka K; Evans M; Lomas J; Sonksen P; Maisey M; Amiel SA
    J Cereb Blood Flow Metab; 1998 Feb; 18(2):130-40. PubMed ID: 9469154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance in patients with cardiac hypertrophy.
    Paternostro G; Pagano D; Gnecchi-Ruscone T; Bonser RS; Camici PG
    Cardiovasc Res; 1999 Apr; 42(1):246-53. PubMed ID: 10435017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.
    Tessari P; Nosadini R; Trevisan R; De Kreutzenberg SV; Inchiostro S; Duner E; Biolo G; Marescotti MC; Tiengo A; Crepaldi G
    J Clin Invest; 1986 Jun; 77(6):1797-804. PubMed ID: 3519679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
    Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
    J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study.
    Bingham EM; Hopkins D; Smith D; Pernet A; Hallett W; Reed L; Marsden PK; Amiel SA
    Diabetes; 2002 Dec; 51(12):3384-90. PubMed ID: 12453890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tomographic mapping of kinetic rate constants in the fluorodeoxyglucose model using dynamic positron emission tomography.
    Sasaki H; Kanno I; Murakami M; Shishido F; Uemura K
    J Cereb Blood Flow Metab; 1986 Aug; 6(4):447-54. PubMed ID: 3488323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperinsulinemia suppresses glucose utilization in specific brain regions: in vivo studies using the euglycemic clamp in the rat.
    Grunstein HS; James DE; Storlien LH; Smythe GA; Kraegen EW
    Endocrinology; 1985 Feb; 116(2):604-10. PubMed ID: 3967621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [18F]fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin.
    Minn H; Leskinen-Kallio S; Lindholm P; Bergman J; Ruotsalainen U; Teräs M; Haaparanta M
    J Comput Assist Tomogr; 1993; 17(1):115-23. PubMed ID: 8419418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.